Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Eiber, Matthias; Herrmann, Ken; Calais, Jérémie; Hadaschik, Boris; L. Giesel, Frederik; Hartenbach, Markus; A. Hope, Thomas; E. Reiter, Robert; Maurer, Tobias; Weber, Wolfgang; P. Fendler, Wolfgang

doi:10.2967/jnumed.117.198119

Public

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Published in Journal of Nuclear Medicine • Nov 9, 2017

Authors:

Matthias Eiber

Ken Herrmann

Jérémie Calais

Abstract

Prostate-specific membrane antigen (PSMA)-ligand PET imaging provides unprecedented accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly adopted in clinical trials and routine practice worldwide, a unified language for image reporting is urgently needed. We propo...

Subject

Prostate cancer

Glutamate carboxypeptidase II

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!